Adverse Drug Reactions Arising from the Use of the Products Outside the Terms of the Marketing AuthorisationAdverse Drug Reactions Arising from the Use of the Products Outside the Terms of the Marketing Authorisation

Autor: Mirošević Skvrce, N., Mucalo, I., Galić, I., Pacadi, C., Kandžija, N.

Background/Introduction: New European (EU) pharmacovigilance (PV) legislation, introduced in 2012, widened the scope of an Adverse Drug Reactions definition so that it also includes noxious and unintended response to a medicinal product arising from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::5bdecd1d8838c316e3ba1b07698506a7
https://www.bib.irb.hr/1270374

Factors Facilitating and Hindering Development of a Medication Use Review Service in Eastern Europe and Iran-Cross-Sectional Exploratory Study.

Autor: Tuula A; Institute of Pharmacy, University of Tartu, 50411 Tartu, Estonia., Volmer D; Institute of Pharmacy, University of Tartu, 50411 Tartu, Estonia., Jõhvik L; Hospital Pharmacy, Tartu University Hospital, 50406 Tartu, Estonia., Rutkovska I; Faculty of Pharmacy, Riga Stradins University, LV-1007 Riga, Latvia., Trečiokienė I; Pharmacy Center, Faculty of Medicine, Vilnius University, 01513 Vilnius, Lithuania., Merks P; Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, 01-938 Warsaw, Poland., Waszyk-Nowaczyk M; Department of Pharmaceutical Technology, Pharmacy Practice Division, Poznan University of Medical Sciences, 60-780 Poznan, Poland., Drozd M; Department of Humanities and Social Medicine, Medical University of Lublin, 20-093 Lublin, Poland., Tatarević A; Istrian Pharmacies, 52100 Pula, Croatia., Radovanlija M; Pharmacy Rajić, 34000 Požega, Croatia., Pacadi C; Mandis Pharm Community Pharmacies, 10000 Zagreb, Croatia., Meštrović A; Pharma Expert Consultancy and Education, 10040 Zagreb, Croatia., Viola R; Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary., Soós G; Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary., Rais C; Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania., Táerel AE; Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania., Kuzelova M; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, 83232 Bratislava, Slovakia., Zare M; Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran., Peymani P; Rady Faculty of Health Sciences, College of Pharmacy, University of Manitoba, Winnipeg, MB R3E 0T5, Canada., Oona M; Institute of Family Medicine and Public Health, University of Tartu, 50411 Tartu, Estonia., Scott M; Medicines Optimisation Innovation Centre, Antrim BT41 2RL, UK.

Publikováno v: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2021 Sep 14; Vol. 9 (9). Date of Electronic Publication: 2021 Sep 14.

MEDICATION ERRORS DETECTED AMONG THE SPONTANEOUSLY REPORTED ADVERSE DRUG REACTIONS TO THE CROATIAN AGENCY FOR MEDICINAL PRODUCTS AND MEDICAL DEVICES

Autor: Macolić Šarinić, M., Kandžija, N., Pacadi, C., Mucalo, I., Ortner Hadžiabdić, M., Krnić, D., Mirošević Skvrce, N.

Background: Medication errors are the most common preventable cause of adverse drug reactions (ADRs) in medication practice and present a major public health burden. Aim of the study: The objective of the study was to identify, evaluate and describe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2b6d9cbecd76aa79cded795a1198caa4
https://www.bib.irb.hr/1270732

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system.

Autor: Wei Wei, Liang Huang, Yingtao Bai, En Chang, Jinfeng Liu

Publikováno v: Frontiers in Pharmacology; 2024, p1-15, 15p